BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TRACON Pharmaceuticals, Inc. 

4510 Executive Drive
Suite 330
San Diego  California  92121  U.S.A.
Phone: 858-550-0780 Fax: 858-550-0786


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
TRACON Pharmaceuticals, Inc. Appoints William Larue To Its Board Of Directors 8/4/2014 9:01:57 AM
Santen Pharmaceutical And TRACON Pharmaceuticals, Inc. Announce Agreement For The Development And Commercialization Of TRC105 In Ophthalmology 3/4/2014 11:38:33 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 1b Study Of TRC105 In Patients With Advanced Soft Tissue Sarcoma 2/4/2014 9:27:32 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 1b Study of TRC105 in Patients With Metastatic Renal Cell Carcinoma 9/24/2013 9:22:24 AM
TRACON Pharmaceuticals, Inc. Announces TRC105 Clinical Trials, Abstract Presentations at 2013 American Society of Clinical Oncology Annual Meeting 5/20/2013 6:47:46 AM
TRACON Pharmaceuticals, Inc. Announces Appointment of Kenneth Galbraith as Chairman of the Board 12/6/2011 10:07:42 AM
TRACON Pharmaceuticals, Inc. Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development 4/20/2011 6:50:10 AM
TRACON Pharmaceuticals, Inc. Announces Upcoming Scientific Presentations on Clinical-Stage Cancer Therapeutics TRC105 and TRC102 10/25/2010 9:15:56 AM
TRACON Pharmaceuticals, Inc. to Present Three First-in-Class Oncology Therapeutics (TRC105, TRC102, and TRC093) at the American Society of Clinical Oncology 2010 Annual Meeting 5/19/2010 8:30:54 AM
TRACON Pharmaceuticals, Inc. Announces Start of Phase 1/2 Trial of TRC105 Antibody Therapy for Prostate Cancer 4/26/2010 9:00:53 AM
123